How do we solve the problem of apathy in neuro-oncology research?
Rachael Babin chats to Lance Kawaguchi about the Cure Brain Cancer Foundation’s Clinical Accelerator.
Cure Brain Cancer Foundation recently launched the world’s largest brain-cancer dedicated Clinical Accelerator program – with up to $2million in funding to support brain cancer research and fast-track treatment to patients. This is in addition to an Early Career Research Fellowship the Foundation has recently awarded, worth $345,000.
Available across Australia and New Zealand, the clinical accelerator program will support researchers to progress ideas from early-stage, pre-clinical research, into therapeutic products that show proof-of-concept and viability for industry partnership and investment.
Rachael Babin chats to Lance Kawaguchi about the Cure Brain Cancer Foundation’s Clinical Accelerator.
In this candid interview Rachael Babin and Lance Kawaguchi discuss why brain cancer research funding lags behind other tumour streams and Lance’s personal motivations for moving from the world of finance and banking to oncology advocacy. This podcast offers refreshing insights into investors’ attitudes, Australia’s standing in global biotech and the future role of the blockchain in healthcare.
Lance Kawaguchi:
Mr Lance Kawaguchi is an internationally recognised executive leader and board member, with over 25 years of global finance and banking experience, including living and working throughout North America, Europe, Asia Pacific, and the Middle East.
He has a strong advocational vision for supporting people and families living with brain cancer, while advancing the foundation’s visibility and objectives with like-minded members of the global corporate and scientific community.
Lance has experienced first-hand the impacts of cancer, losing his mother to the disease in 2016. In her memory, he has committed to utilising his skills and talents to positively impact and drive change in the sector.
Throughout his career, Lance’s outstanding leadership and innovative approach to diversity and inclusion have seen him recognised by many peak global bodies including the Treasury Management International, prestigious BAME100 Board Talent Index and as one of UPstanding’s 100 leading ethnic minority executives.
Rachael Babin
Rachael Babin is the Executive Officer of The Oncology Network. This role includes being Host of The Oncology Podcast, Editor-in-Chief of The Oncology Newsletter, Publisher of Oncology News Australia, and Producer of The Oncology Journal Club.
With a background in oncology communications and academic publishing, Rachael is happiest sitting behind the mic chatting to interesting people about the impact their work makes in oncology.
Connect with us on Twitter here: @OncologyNewsAus
